Newzicc: Zim Laboratories to be listed on BSE tomorrow

Zim Labs was trading on the OTC Exchange Of India before the Securities Exchange Board of India (SEBI) withdrew its recognition of it in March 2015. The company was recently by allowed SEBI to list on the main board of BSE. The book value of Zim Labs, promoted by Anwar Daud, is Rs 160 per equity share. Started in 1989, Zim clocked a profit after tax of Rs 18 crore on revenue of Rs 275 crore in FY18. Zim has developed and commercialised the complex oral film technology and plans to launch multi-layer thin films that contain more than one API on a single thin strip in coming months.

Original Article 


Popular posts from this blog

ZIMLab's Dr.Nidhi Sapkal delivered talk on "Technology development of Bi/Multilayer thin films" at International Conference on Pharmaceutical Development and Technology,Osaka, Japan.

ZIM Lab announces approval for Vitamin D3 Orally Disintegrating Film

ZIM’s exclusive Oral Thin Film manufacturing technology - ‘Thinoral®’